MedTrace Logo

Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis

NCT06624189 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 1300

Last updated 2026-02-27

No results posted yet for this study

Summary

The research team will evaluate the effectiveness of an auto-pended bot liver ultrasound order that will prompt providers at the time of encounter to place appropriate imaging orders for hepatocellular carcinoma (HCC) screening in patients with cirrhosis.

Conditions

Interventions

OTHER

Auto-pended bot liver ultrasound order

This alert prompt providers at the time of encounter to place appropriate imaging orders for hepatocellular carcinoma (HCC) screening in patients with cirrhosis.

Sponsors & Collaborators

Principal Investigators

  • Saul Blecker · NYU Langone Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-20
Primary Completion
2026-04-24
Completion
2026-07-24

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06624189 on ClinicalTrials.gov